Cognitive impairment in practice of therapist
Abstract
Cognitive disorders are of great social importance and are interdisciplinary problem, as occur in many diseases: cardiovascular diseases, diabetes, obesity, etc. An important role in the development of cognitive disorders plays hypertension. Treating cognitive disorders should include a healthy lifestyle, avoiding harmful habits and also therapy of the underlying disease. Among drugs with metabolic, neuroprotective effect clinical studies confirmed the high efficiency of Actovegin.
About the Authors
I. I. Chukaeva
Russian National Research Medical University n.a. N. I. Pirogov
Russian Federation
Russian Federation
V. N. Larina
Russian National Research Medical University n.a. N. I. Pirogov
Russian Federation
Russian Federation
N. V. Orlova
Russian National Research Medical University n.a. N. I. Pirogov
Russian Federation
Russian Federation
E. V. Kudina
Russian National Research Medical University n.a. N. I. Pirogov
Russian Federation
Russian Federation
References
1. Delrieu J., Andrieu S., Pahor M., Cantet C., Cesari M., Ousset P., Voisin T., Fougere B., Gillette S., Carrie I., Vellas B. Neuropsychological Profile of “Cognitive Frailty" Subjects in MAPT Study. J Prev Alzheimers Dis 2016; 3 (3): 151-159.
2. Folstein M., Folstein S., McHugh P. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12 (3): 189-198.
3. Knopman D., Mosley T., Catellier D., Sharrett A. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 2005; 65: 876-881.
4. Kivipelto M., Ngandu T., Fratiglioni L. et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556-1560.
5. Johnson K., Margolis K., Espeland M. et al. Women’s Health Initiative Memory Study and Women’s Health Initiative Investigators. A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women’s Health Initiative Memory Study / /J Am Geriatr Soc. 2008. V. 56. P. 1449-1458.
6. Giordano N., Tikhonoff V., Palatini P. et al. Cognitive functions and cognitive reserve in relation to blood pressure components in a population-based cohort aged 53 to 94 years. Int J Hypertens 2012; article ID274851, p. 8.
7. Alexander R. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 2 (25): 155-161.
8. Birns J., Morris R., Donaldson N., Kalra L. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006; 24: 1907-1914.
9. Vogels R., Scheltens P., Schroeder-Tanka J., Weinstein H. Cognitive impairment in heart failure: A systematic review of the literature. Eur J Heart Fail 2007; 5 (9): 440^49.
10. Kristine Yaffe Anemia and risk of dementia in older adults Neurology. MedWeb, 2017.
11. Murad K., Goff D., Morgan T., Burke G., Bartz T., Kizer J., Chaudhry S., Gottdiener J. Kitzman D. Burden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study. JACC Heart Fail. 2015. 3 (7): 542-550.
12. Forette F., Seux M., Staussen J. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study // Arch. Intern. Med. 2002. № 14. V. 162 (18). P. 2046-2052.
13. Kearney-Schwartz A., Rossignol P., Bracard S. et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints // Stroke. 2009. V. 40. P. 1229-1236.
14. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
15. Frith E., Lopinzi P. Physical activity and cognitive function among older adults with hypertension. J Hypertens. 2017 Feb 17. doi: 10.1097/ HJH.0000000000001311. Epub ahead of print.
16. Edwards M., Loprinzi P. The Association Between Sedentary Behavior and Cognitive Function Among Older Adults May Be Attenuated With Adequate Physical Activity. J Phys Act Health. 2017; 14 (1): 52-58.
17. Кузнецов М. Р., Вирганский А. О., Косых И. В., и др. Возможности метаболической терапии при атеросклерозе. Неврологический журнал № 4,2014. С. 56-60.
18. Шавловская О. А. Новые аспекты применения Актовегина: от механизмов действия к клиническим эффектам. Эффективная фармакотерапия. 9/2016. С. 4-6.
19. Федорович А. А., Соболева Г. Н. Коррекция когнитивных нарушений препаратом Актовегин у пациентов с артериальной гипертензией и ишемической болезнью сердца. Эффективная фармакотерапия. 23/2015. С. 30-38.
20. Остроумова О. Д., Галеева Н. Ю., Первинко Е. И. Коррекция когнитивных нарушений Актовегином у больных гипертонической болезнью. Медицинский алфавит. Больница - все для ЛПУ. 2012, 4: С. 3-6.
21. Фонякин А. В., Гераскина Л. А. Лечение и профилактика сосудистых когнитивных расстройств при артериальной гипертензии. Consilium Medicum: Неврология и ревматология № 1 2016. С. 28-32.
22. Борискина Л. М. Эффективность Актовегина при лечении заболеваний центральной и периферической нервной системы. Нервно-мышечные болезни. 2/2015. С. 25-31.
23. Танашян М. М., Бархатов Д. Ю., Коновалов Р. Н. Когнитивные расстройства и астенические проявления при церебральном атеросклерозе и гипертонии на фоне метаболического синдрома. Атмосфера. Нервные болезни 2014 № 2. С. 20-24.
24. Евдокимова А. Г., Евдокимов В. В. Оптимизация лечения гипертонической энцефалопатии с использованием нейропротекторной терапии Актовегином. Опыт клинического применения. Кардиология и ангиология. 2/2012. С. 10-16.
25. Захаров В. В., Соснина В. Б. Применение антигипоксантов в лечении когнитивных нарушений у больных с сахарным диабетом // Неврологический журнал. 2008. № 5. Стр. 39-43.
Review
For citations:
Chukaeva I.I., Larina V.N., Orlova N.V., Kudina E.V. Cognitive impairment in practice of therapist. Medical alphabet. 2017;1(4):18-24. (In Russ.)
Views:
333
Email this article 